Guilin Sanjin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Guilin Sanjin Pharmaceutical has a total shareholder equity of CN¥2.9B and total debt of CN¥375.9M, which brings its debt-to-equity ratio to 12.9%. Its total assets and total liabilities are CN¥3.8B and CN¥898.6M respectively. Guilin Sanjin Pharmaceutical's EBIT is CN¥421.7M making its interest coverage ratio -220.9. It has cash and short-term investments of CN¥1.3B.
Key information
12.9%
Debt to equity ratio
CN¥375.93m
Debt
Interest coverage ratio | -220.9x |
Cash | CN¥1.32b |
Equity | CN¥2.91b |
Total liabilities | CN¥898.60m |
Total assets | CN¥3.81b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002275's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥664.9M).
Long Term Liabilities: 002275's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥233.7M).
Debt to Equity History and Analysis
Debt Level: 002275 has more cash than its total debt.
Reducing Debt: 002275's debt to equity ratio has increased from 3.5% to 12.9% over the past 5 years.
Debt Coverage: 002275's debt is well covered by operating cash flow (138.3%).
Interest Coverage: 002275 earns more interest than it pays, so coverage of interest payments is not a concern.